Found: 279
Select item for more details and to access through your institution.
Implications of UKPDS evidence.
- Published in:
- Practice Nursing, 2010, v. 21, n. 3, p. 140, doi. 10.12968/pnur.2010.21.3.46934
- By:
- Publication type:
- Article
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1832, doi. 10.1007/s00125-023-05988-3
- By:
- Publication type:
- Article
Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England.
- Published in:
- Diabetologia, 2023, v. 66, n. 4, p. 657, doi. 10.1007/s00125-022-05854-8
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2022, v. 65, n. 12, p. 1925, doi. 10.1007/s00125-022-05787-2
- By:
- Publication type:
- Article
Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
- Published in:
- Diabetologia, 2020, v. 63, n. 10, p. 2129, doi. 10.1007/s00125-020-05223-3
- By:
- Publication type:
- Article
Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials.
- Published in:
- Diabetologia, 2020, v. 63, n. 8, p. 1516, doi. 10.1007/s00125-020-05174-9
- By:
- Publication type:
- Article
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD).
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2020, v. 63, n. 2, p. 221, doi. 10.1007/s00125-019-05039-w
- By:
- Publication type:
- Article
Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2018, v. 61, n. 12, p. 2461, doi. 10.1007/s00125-018-4729-5
- By:
- Publication type:
- Article
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.
- Published in:
- Diabetologia, 2018, v. 61, n. 7, p. 1592, doi. 10.1007/s00125-018-4626-y
- By:
- Publication type:
- Article
Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 8, p. 839, doi. 10.1007/s00592-019-01293-x
- By:
- Publication type:
- Article
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 3, p. 331, doi. 10.1007/s00592-018-1253-5
- By:
- Publication type:
- Article
Metabolic Effects of Breaking Prolonged Sitting With Standing or Light Walking in Older South Asians and White Europeans: A Randomized Acute Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hotspots: Adherence in home foot temperature monitoring interventions for at‐risk feet with diabetes—A narrative review.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 10, p. 1, doi. 10.1111/dme.15189
- By:
- Publication type:
- Article
Structured group education programme and accompanying mHealth intervention to promote physical activity in women with a history of gestational diabetes: A randomised controlled trial.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 7, p. 1, doi. 10.1111/dme.15118
- By:
- Publication type:
- Article
Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 6, p. 1, doi. 10.1111/dme.15083
- By:
- Publication type:
- Article
Evaluation of quality of diabetic foot examination on YouTube.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 1, p. 1, doi. 10.1111/dme.14936
- By:
- Publication type:
- Article
Fibro‐inflammatory recovery and type 2 diabetes remission following a low calorie diet but not exercise training: A secondary analysis of the DIASTOLIC randomised controlled trial.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 8, p. 1, doi. 10.1111/dme.14884
- By:
- Publication type:
- Article
Relative protein intake and associations with markers of physical function in those with type 2 diabetes.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 8, p. 1, doi. 10.1111/dme.14851
- By:
- Publication type:
- Article
Structured diabetes self‐management education and glycaemic control in low‐ and middle‐income countries: A systematic review.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 8, p. 1, doi. 10.1111/dme.14812
- By:
- Publication type:
- Article
Attitudes of older adults and their carers towards de‐prescribing: A systematic review.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 7, p. 1, doi. 10.1111/dme.14801
- By:
- Publication type:
- Article
Chronotype and well-being in adults with established type 2 diabetes: A cross-sectional study.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 3, p. 1, doi. 10.1111/dme.14690
- By:
- Publication type:
- Article
Individual, healthcare professional and system‐level barriers and facilitators to initiation and adherence to injectable therapies for type 2 diabetes: A systematic review and meta‐ethnography.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 1, p. 1, doi. 10.1111/dme.14678
- By:
- Publication type:
- Article
Effectiveness of the Transformation model, a model of care that integrates diabetes services across primary, secondary and community care: A retrospective study.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14504
- By:
- Publication type:
- Article
Improved diabetes‐related distress and self‐efficacy outcomes in a self‐management digital programme for people with type 2 diabetes, myDESMOND.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 5, p. 1, doi. 10.1111/dme.14551
- By:
- Publication type:
- Article
Use of MyDesmond digital education programme to support self‐management in people with type 2 diabetes during the COVID‐19 pandemic.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 3, p. 1, doi. 10.1111/dme.14469
- By:
- Publication type:
- Article
Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 4030, doi. 10.1111/dom.15755
- By:
- Publication type:
- Article
Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1837, doi. 10.1111/dom.15500
- By:
- Publication type:
- Article
Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1355, doi. 10.1111/dom.15437
- By:
- Publication type:
- Article
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 512, doi. 10.1111/dom.15337
- By:
- Publication type:
- Article
Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal–bolus insulin in UK clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3841, doi. 10.1111/dom.15278
- By:
- Publication type:
- Article
Real‐world study of ethnic differences in glycaemic control and clinical characteristics among insulin‐naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2756, doi. 10.1111/dom.15165
- By:
- Publication type:
- Article
Semaglutide for the treatment of overweight and obesity: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 18, doi. 10.1111/dom.14863
- By:
- Publication type:
- Article
Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1598, doi. 10.1111/dom.14735
- By:
- Publication type:
- Article
The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1509, doi. 10.1111/dom.14721
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes of initial combination therapy with glucose‐lowering agents versus a stepwise approach in newly diagnosed or treatment‐naïve type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1469, doi. 10.1111/dom.14715
- By:
- Publication type:
- Article
Energy intake and weight during the COVID‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 546, doi. 10.1111/dom.14585
- By:
- Publication type:
- Article
Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan‐O randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 34, doi. 10.1111/dom.14543
- By:
- Publication type:
- Article
Ethnic, social and multimorbidity disparities in therapeutic inertia: A UK primary care observational study in patients newly diagnosed with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 11, p. 2437, doi. 10.1111/dom.14482
- By:
- Publication type:
- Article
Cardiovascular effects of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: The P value and beyond.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1685, doi. 10.1111/dom.14384
- By:
- Publication type:
- Article
Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1301, doi. 10.1111/dom.14340
- By:
- Publication type:
- Article
Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1409, doi. 10.1111/dom.14343
- By:
- Publication type:
- Article
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 425, doi. 10.1111/dom.14234
- By:
- Publication type:
- Article
Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real‐world study of patients followed for up to 19 years.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 218, doi. 10.1111/dom.14218
- By:
- Publication type:
- Article
Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2417, doi. 10.1111/dom.14169
- By:
- Publication type:
- Article
Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1915, doi. 10.1111/dom.14124
- By:
- Publication type:
- Article
Body mass index and the risk of COVID‐19 across ethnic groups: Analysis of UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1953, doi. 10.1111/dom.14125
- By:
- Publication type:
- Article
Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1670, doi. 10.1111/dom.14066
- By:
- Publication type:
- Article
A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1187, doi. 10.1111/dom.14023
- By:
- Publication type:
- Article